Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Guillaume Smits is active.

Publication


Featured researches published by Guillaume Smits.


Nature Cell Biology | 2012

The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r.

Andrew Keniry; David Oxley; Paul Monnier; Michael Kyba; Luisa Dandolo; Guillaume Smits; Wolf Reik

The H19 large intergenic non-coding RNA (lincRNA) is one of the most highly abundant and conserved transcripts in mammalian development, being expressed in both embryonic and extra-embryonic cell lineages, yet its physiological function is unknown. Here we show that miR-675, a microRNA (miRNA) embedded in H19’s first exon, is expressed exclusively in the placenta from the gestational time point when placental growth normally ceases, and placentas that lack H19 continue to grow. Overexpression of miR-675 in a range of embryonic and extra-embryonic cell lines results in their reduced proliferation; targets of the miRNA are upregulated in the H19 null placenta, including the growth-promoting insulin-like growth factor 1 receptor (Igf1r) gene. Moreover, the excision of miR-675 from H19 is dynamically regulated by the stress-response RNA-binding protein HuR. These results suggest that H19’s main physiological role is in limiting growth of the placenta before birth, by regulated processing of miR-675. The controlled release of miR-675 from H19 may also allow rapid inhibition of cell proliferation in response to cellular stress or oncogenic signals.


The EMBO Journal | 2005

Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity.

Eneko Urizar; Lucia Montanelli; Tiffany Loy; Marco Bonomi; Stéphane Swillens; Céline Galés; Michel Bouvier; Guillaume Smits; Gilbert Vassart; Sabine Costagliola

The monomeric model of rhodopsin‐like G protein‐coupled receptors (GPCRs) has progressively yielded the floor to the concept of GPCRs being oligo(di)mers, but the functional correlates of dimerization remain unclear. In this report, dimers of glycoprotein hormone receptors were demonstrated in living cells, with a combination of biophysical (bioluminescence resonance energy transfer and homogenous time resolved fluorescence/fluorescence resonance energy transfer), functional and biochemical approaches. Thyrotropin (TSHr) and lutropin (LH/CGr) receptors form homo‐ and heterodimers, via interactions involving primarily their heptahelical domains. The large hormone‐binding ectodomains were dispensable for dimerization but modulated protomer interaction. Dimerization was not affected by agonist binding. Observed functional complementation indicates that TSHr dimers may function as a single functional unit. Finally, heterologous binding‐competition studies, performed with heterodimers between TSHr and LH/CG–TSHr chimeras, demonstrated the unsuspected existence of strong negative cooperativity of hormone binding. Tracer desorption experiments indicated an allosteric behavior in TSHr and, to a lesser extent, in LH/CGr and FSHr homodimers. This study is the first report of homodimerization associated with negative cooperativity in rhodopsin‐like GPCRs. As such, it may warrant revisitation of allosterism in the whole GPCR family.


The EMBO Journal | 2002

Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors

Sabine Costagliola; Valérie Panneels; Marco Bonomi; J Koch; Marie-Christine Many; Guillaume Smits; Gilbert Vassart

The glycoprotein hormone receptors (thyrotrophin receptor, TSHr; luteinizing hormone/chorionic gonadotrophin receptor, LH/CGr; follicle‐stimulating hormone receptor, FSHr) constitute a subfamily of rhodopsin‐like G protein‐coupled receptors (GPCRs) with a long N‐terminal extracellular extension responsible for high‐affinity hormone binding. These ectodomains contain two cysteine clusters flanking nine leucine‐rich repeats (LRR), a motif found in several protein families involved in protein–protein interactions. Similar to the situation described recently in CCR5, we demonstrate here that the TSHr, as it is present at the cell surface, is sulfated on tyrosines in a motif located downstream of the C‐terminal cysteine cluster. Sulfation of one of the two tyrosines in the motif is mandatory for high‐affinity binding of TSH and activation of the receptor. Site‐directed mutagenesis experiments indicate that the motif, which is conserved in all members of the glycoprotein hormone receptor family, seems to play a similar role in the LH/CG and FSH receptors.


The EMBO Journal | 2003

Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity

Guillaume Smits; Mercedes Campillo; Cédric Govaerts; Véronique Janssens; Christine Richter; Gilbert Vassart; Leonardo Pardo; Sabine Costagliola

Glycoprotein hormone receptors [thyrotropin (TSHr), luteinizing hormone/chorionic gonadotropin (LH/CGr), follicle stimulating hormone (FSHr)] are rhodopsin‐like G protein‐coupled receptors with a large extracellular N‐terminal portion responsible for hormone recognition and binding. In structural models, this ectodomain is composed of two cysteine clusters flanking nine leucine‐rich repeats (LRRs). The LRRs form a succession of β‐strands and α‐helices organized into a horseshoe‐shaped structure. It has been proposed that glycoprotein hormones interact with residues of the β‐strands making the concave surface of the horseshoe. Gain‐of‐function homology scanning of the β‐strands of glycoprotein hormone receptors allowed identification of the critical residues responsible for the specificity towards human chorionic gonadotropin (hCG). Substitution of eight or two residues of the LH/CGr into the TSHr or FSHr, respectively, resulted in constructs displaying almost the same affinity and sensitivity for hCG as wild‐type LH/CGr. Molecular dynamics simulations and additional site‐directed mutagenesis provided a structural rationale for the evolution of binding specificity in this duplicated gene family.


Nature Genetics | 2008

Conservation of the H19 noncoding RNA and H19-IGF2 imprinting mechanism in therians

Guillaume Smits; Andrew J. Mungall; Sam Griffiths-Jones; Paul Smith; Delphine Beury; Lucy Matthews; Jane Rogers; Andrew J. Pask; Geoff Shaw; John L. VandeBerg; John R. McCarrey; Marilyn B. Renfree; Wolf Reik; Ian Dunham

Comparisons between eutherians and marsupials suggest limited conservation of the molecular mechanisms that control genomic imprinting in mammals. We have studied the evolution of the imprinted IGF2-H19 locus in therians. Although marsupial orthologs of protein-coding exons were easily identified, the use of evolutionarily conserved regions and low-stringency Bl2seq comparisons was required to delineate a candidate H19 noncoding RNA sequence. The therian H19 orthologs show miR-675 and exon structure conservation, suggesting functional selection on both features. Transcription start site sequences and poly(A) signals are also conserved. As in eutherians, marsupial H19 is maternally expressed and paternal methylation upstream of the gene originates in the male germline, encompasses a CTCF insulator, and spreads somatically into the H19 gene. The conservation in all therians of the mechanism controlling imprinting of the IGF2-H19 locus suggests a sequential model of imprinting evolution.


Journal of Medical Genetics | 2013

FGFR1 mutations cause Hartsfield syndrome, the unique association of holoprosencephaly and ectrodactyly

Nicolas Simonis; Isabelle Migeotte; Nelle Lambert; Camille Perazzolo; Deepthi De Silva; Boyan Dimitrov; Claudine Heinrichs; Sandra Janssens; Bronwyn Kerr; Geert Mortier; Guy Van Vliet; Philippe Lepage; Georges Casimir; Marc Abramowicz; Guillaume Smits; Catheline Vilain

Background Harstfield syndrome is the rare and unique association of holoprosencephaly (HPE) and ectrodactyly, with or without cleft lip and palate, and variable additional features. All the reported cases occurred sporadically. Although several causal genes of HPE and ectrodactyly have been identified, the genetic cause of Hartsfield syndrome remains unknown. We hypothesised that a single key developmental gene may underlie the co-occurrence of HPE and ectrodactyly. Methods We used whole exome sequencing in four isolated cases including one case-parents trio, and direct Sanger sequencing of three additional cases, to investigate the causative variants in Hartsfield syndrome. Results We identified a novel FGFR1 mutation in six out of seven patients. Affected residues are highly conserved and are located in the extracellular binding domain of the receptor (two homozygous mutations) or the intracellular tyrosine kinase domain (four heterozygous de novo variants). Strikingly, among the six novel mutations, three are located in close proximity to the ATPs phosphates or the coordinating magnesium, with one position required for kinase activity, and three are adjacent to known mutations involved in Kallmann syndrome plus other developmental anomalies. Conclusions Dominant or recessive FGFR1 mutations are responsible for Hartsfield syndrome, consistent with the known roles of FGFR1 in vertebrate ontogeny and conditional Fgfr1-deficient mice. Our study shows that, in humans, lack of accurate FGFR1 activation can disrupt both brain and hand/foot midline development, and that FGFR1 loss-of-function mutations are responsible for a wider spectrum of clinical anomalies than previously thought, ranging in severity from seemingly isolated hypogonadotropic hypogonadism, through Kallmann syndrome with or without additional features, to Hartsfield syndrome at its most severe end.


European Journal of Medical Genetics | 2014

Implementation of genomic arrays in prenatal diagnosis: The Belgian approach to meet the challenges

Olivier Vanakker; Catheline Vilain; Katrien Janssens; Nathalie Van der Aa; Guillaume Smits; Claude Bandelier; Bettina Blaumeiser; Saskia Bulk; Jean-Hubert Caberg; Anne De Leener; Marjan De Rademaeker; Thomy de Ravel; Julie Désir; A Destree; Annelies Dheedene; Stéphane Gaillez; Bernard Grisart; Ann-Cécile Hellin; Sandra Janssens; Kathelijn Keymolen; Björn Menten; Bruno Pichon; Marie Ravoet; Nicole Revencu; Sonia Rombout; Catherine Staessens; Ann Van Den Bogaert; Kris Van Den Bogaert; Joris Vermeesch; Frank Kooy

After their successful introduction in postnatal testing, genome-wide arrays are now rapidly replacing conventional karyotyping in prenatal diagnostics. While previous studies have demonstrated the advantages of this method, we are confronted with difficulties regarding the technology and the ethical dilemmas inherent to genomic arrays. These include indication for testing, array design, interpretation of variants and how to deal with variants of unknown significance and incidental findings. The experiences with these issues reported in the literature are most often from single centres. Here, we report on a national consensus approach how microarray is implemented in all genetic centres in Belgium. These recommendations are subjected to constant re-evaluation based on our growing experience and can serve as a useful tool for those involved in prenatal diagnosis.


Cellular and Molecular Life Sciences | 2008

The specificity of binding of glycoprotein hormones to their receptors.

Gianluigi Caltabiano; Mercedes Campillo; A. De Leener; Guillaume Smits; Gilbert Vassart; Sabine Costagliola; Leonardo Pardo

Abstract.The glycoprotein hormone receptor family is peculiar because, in contrast to other G protein-coupled receptors, a large N-terminal extracellular ectodomain is responsible for hormone recognition. Hormone-receptor pairs have evolved in such a manner that a limited number of positions both at the ‘seat-belt’ domain of the hormone and the leucine-rich repeats of the receptor, play attractive and repulsive interactions for binding and specificity, respectively. Surprisingly, the constitutive activity of the receptor, mostly modulated by highly conserved amino acids within the heptahelical domain of the receptor (i.e., outside the hormone binding region), also regulates effectiveness of hormone recognition by the extracellular part. In this review we analyze, at the molecular level, these important discriminating determinants for selective binding of glycoprotein hormones to their receptors, as well as natural mutations, observed in patients with gestational hyperthyroidism or ovarian hyperstimulation syndrome, that modify the selectivity of binding.


Endocrine | 2005

Understanding ovarian hyperstimulation syndrome

Anne Delbaere; Guillaume Smits; Anne De Leener; Sabine Costagliola; Gilbert Vassart

The ovarian hyperstimulation syndrome (OHSS) is a potentially life-threatening complication of ovarian stimulation treatments. Severe forms are characterized by a massive ovarian enlargement with the formation of multiple ovarian cysts associated with extravascular fluid shifts resulting in the development of ascites, pleural and/or pericardial effusion. The pathophysiology of the syndrome has not been completely elucidated yet. The vascular fluid leakage is thought to result from an increased capillary permeability of mesothelial surfaces under the action of one or several vasoactive ovarian factor(s) produced by the multiple corpora lutea. The paper focuses on the recent identification of mutations in the FSH receptor gene that display an increased sensitivity to hCG and are responsible for the development of spontaneous OHSS occurring during pregnancy. These findings have shed light for the first time on the molecular basis of the pathophysiology of the spontaneous form of the syndrome. As spontaneous and iatrogenic OHSS share similar pathophysiological sequences including massive recruitment and growth of ovarian follicles, extensive luteinization provoked by hCG, and oversecretion of vasogenic molecules by the corpora lutea, they have also opened new research perspectives for the understanding of the much more frequent iatrogenic OHSS.


EMBO Reports | 2007

Non-coding transcripts in the H19 imprinting control region mediate gene silencing in transgenic Drosophila

Stefan Schoenfelder; Guillaume Smits; Peter Fraser; Wolf Reik; Renato Paro

The imprinting control region (ICR) upstream of H19 is the key regulatory element conferring monoallelic expression on H19 and Igf2 (insulin‐like growth factor 2). Epigenetic marks in the ICR regulate its interaction with the chromatin protein CCCTC‐binding factor and with other control factors to coordinate gene silencing in the imprinting cluster. Here, we show that the H19 ICR is biallelically transcribed, producing both sense and antisense RNAs. We analyse the function of the non‐coding transcripts in a Drosophila transgenic system in which the H19 upstream region silences the expression of a reporter gene. We show that knockdown of H19 ICR non‐coding RNA (ncRNA) by RNA interference leads to the loss of reporter gene silencing. Our results are, to the best of our knowledge, the first to show that ncRNAs in the H19 ICR are functionally significant, and also indicate that they have a role in regulating gene expression and perhaps epigenetic marks at the H19/Igf2 locus.

Collaboration


Dive into the Guillaume Smits's collaboration.

Top Co-Authors

Avatar

Gilbert Vassart

Université libre de Bruxelles

View shared research outputs
Top Co-Authors

Avatar

Sabine Costagliola

Université libre de Bruxelles

View shared research outputs
Top Co-Authors

Avatar

Anne Delbaere

Université libre de Bruxelles

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Leonardo Pardo

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Catheline Vilain

Free University of Brussels

View shared research outputs
Top Co-Authors

Avatar

Sandra Janssens

Ghent University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bruno Pichon

Université libre de Bruxelles

View shared research outputs
Researchain Logo
Decentralizing Knowledge